How willing are we to say “no” to more spending and more questionably-effective drugs? Published by Jane the Actuary View all posts by Jane the Actuary
2 thoughts on “Forbes post, “The FDA Approves The Alzheimer’s Drug Aducanumab — And Reminds Us Of The Herculean Task Of Medicare Reform””